(in millions, except per share amounts and percentages)
(unaudited)
RECONCILIATION OF GAAP GROSS PROFIT TO NON-GAAP GROSS PROFIT
| Three Months Ended June 30, | |||||||
| 2022 | 2021 | ||||||
| Gross profit, as reported | $ | 1,309.9 | $ | 1,007.6 | |||
| Share-based compensation expense | 7.7 | 8.8 | |||||
| Non-GAAP gross profit | $ | 1,317.6 | $ | 1,016.4 | |||
| Non-GAAP gross profit percentage | 67.1 | % | 64.8 | % | |||
RECONCILIATION OF GAAP RESEARCH AND DEVELOPMENT EXPENSES TO NON-GAAP RESEARCH AND DEVELOPMENT EXPENSES
| Three Months Ended June 30, | |||||||
| 2022 | 2021 | ||||||
| Research and development expenses, as reported | $ | 269.0 | $ | 238.4 | |||
| Share-based compensation expense | (20.1 | ) | (26.6 | ) | |||
| Acquisition-related | (0.2 | ) | (0.2 | ) | |||
| Non-GAAP research and development expenses | $ | 248.7 | $ | 211.6 | |||
| Non-GAAP research and development expenses as a percentage of net sales | 12.7 | % | 13.5 | % | |||
